Telfast 180 mg 20 tablets

Tradename

Telfast

Telfast

Structure:

Each film-coated tablet contains 180 mg of Fexofenadine hydrochloride.

Pharmacological group:

Antiallergic agent.

Pharmacological properties:

Telfast is an antihistamine drug that is an antagonist of histamine H-1 receptors. Does not sedate or otherwise affect the central nervous system. The antiallergic effect appears after 1 hour, after a maximum of 6 hours, continues to act for 24 hours.

Indications

elimination of symptoms associated with seasonal allergic rhinitis (SAR) or urticaria for adults and children over 12 years old.

Mode of application:

SAR symptoms and urticaria: 180mg once daily before meals.

Contraindications

hypersensitivity to fexofenadine, terfenadine or other components of the drug.

Side effects

Fexofenadine is generally well tolerated. The most common (1-10% of cases) reported headache, fatigue, dizziness or drowsiness, and nausea. In placebo-controlled studies with a frequency of less than 1%, weakness, insomnia, nervousness, sleep disturbance, tachycardia, palpitations, and diarrhea were noted. In rare cases (less than 0.1%), exanthema, urticaria, itching, Quincke’s edema, shortness of breath, shortness of breath, reddening of the skin, anaphylactic reactions were observed.

Pregnancy Category B:

There are no adequate and well-controlled studies in pregnant women. Fexofenadine should be used during pregnancy only if the potential benefitjustifies the potential risk to the fetus.

Storage

Store at room temperature out of reach of children.

Packaging:

a cardboard box contains 2 blisters, each containing 10 tablets and paper instructions.